Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Net Margin (2016 - 2025)

iBio (IBIO) has disclosed Net Margin for 16 consecutive years, with 5670.0% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin changed N/A to 5670.0% in Q3 2025 year-over-year; TTM through Dec 2025 was 8229.0%, a 464980.0% decrease, with the full-year FY2025 number at 4594.25%, down 38803.0% from a year prior.
  • Net Margin was 5670.0% for Q3 2025 at iBio, down from 2581.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 10.39% in Q2 2021 to a low of 6254.76% in Q3 2021.
  • A 5-year average of 2478.86% and a median of 2182.0% in 2024 define the central range for Net Margin.
  • Biggest YoY gain for Net Margin was 392874bps in 2021; the steepest drop was -440135bps in 2021.
  • iBio's Net Margin stood at 6254.76% in 2021, then soared by 89bps to 688.33% in 2022, then tumbled by -95bps to 1344.0% in 2023, then crashed by -62bps to 2182.0% in 2024, then plummeted by -160bps to 5670.0% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Net Margin are 5670.0% (Q3 2025), 2581.5% (Q2 2025), and 2182.0% (Q4 2024).